Table 2.
Summary of data of SARS-CoV-2 infected IEI patients in relation to main circulating strains, administered treatment, hospital admission and duration of positive swab.
| Time frame | Main circulating VOC | Number of patients | Number of patients withSevere COVID-19 | Medianduration of swab positivity (days) | Number of treated patientsmabs | Number of treated patientsantivirals | Number of treated patientsmabs+antivirals | Hospital admissions | Medianhospitalization (days) |
|---|---|---|---|---|---|---|---|---|---|
| 01/02/2020 31/12/2020 |
Wuhan | 31 | 9 | 23 (15.5-41.5) |
2 | 6 | 2 | 11 | 30.81 (7-90) |
| 01/01/2021 14/07/2021 |
Alpha | 26 | 1 | 22 (18.75-27.5) |
7 | 5 | 0 | 5 | 16.2 (6-34) |
| 15/07/2021 25/12/2021 |
Delta | 14 | 3 | 17 (9.75-20.00) |
8 | 0 | 0 | 4 | 56 (5-195) |
| 26/12/2021 15/05/2022 |
Omicron | 121 | 3 | 14 (10.00-25.00) |
66 | 36 | 4 | 8 | 18.13 (3-40) |